Sarah Spreckelmeyer

Head of Radiopharmacy

Charité - Universitätsmedizin Berlin

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sarah Spreckelmeyer is the Head of Radiopharmacy at Charité - University Medicine Berlin. Her research focuses on radiopharmaceutical design and optimization, as evidenced by her recent publications on various aspects of radiochemistry and radiopharmacy, including the development of new platforms for radiopharmaceuticals and the evaluation of radiolabeled compounds. She is dedicated to advancing the field through innovative solutions and sustainable practices in nuclear medicine.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Collaborators (2)

Bart Cornelissen

UHD (associate professor)

University Medical Center Groningen

NETHERLANDS

View details

Winfried Brenner

Chair/Professor Dr.

Charité - Universitätsmedizin Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sarah Spreckelmeyer

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

N-Heterocyclic Carbenes as Ligands to 198Au(I)-Radiolabeled Compounds: A New Platform for Radiopharmaceutical Design

Correction: Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

How green are radiopharmaceutical sciences?

Optimization of 177 Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application.

Evaluation of the 177m Lu-concentration in in-house produced 177 Lu-radiopharmaceuticals and commercially available Lutathera®.

Metallacages with 2,6-dipicolinoylbis(N,N-dialkylthioureas) as novel platforms in nuclear medicine for 68 Ga, 177 Lu and 198 Au.

Technetium Complexes with an Isocyano-alkyne Ligand and Its Reaction Products

Gold-Based Coronands as Hosts for M3+ Metal Ions: Ring Size Matters

Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

Good practices for 68Ga radiopharmaceutical production

[The Youngsters of the German Society of Nuclear Medicine (Young DGN)].

Fully-automated production of [68Ga]Ga-FAPI-46 for clinical application

Fully-automated production of [68Ga]Ga-PentixaFor on the module Modular Lab-PharmTracer

Collaborators (2)

Bart Cornelissen

Winfried Brenner

Make your next move.